Dan Ploug Christensen
University of Copenhagen(DK)Novo Nordisk Foundation(DK)
Publications by Year
Research Areas
Pancreatic function and diabetes, Histone Deacetylase Inhibitors Research, Genetics and Neurodevelopmental Disorders, Diabetes and associated disorders, Parkinson's Disease Mechanisms and Treatments
Most-Cited Works
- → Histone Deacetylase (HDAC) Inhibition as a Novel Treatment for Diabetes Mellitus(2011)259 cited
- → Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis(2021)129 cited
- → 6α-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice(2022)118 cited
- → Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children(2012)92 cited
- → An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection(2015)83 cited
- → Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines(2010)71 cited
- → Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection(2014)70 cited
- → Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson’s disease patient fibroblasts(2019)66 cited
- → Transcriptional and translational regulation of cytokine signaling in inflammatory β-cell dysfunction and apoptosis(2012)46 cited
- → Altering β-cell number through stable alteration of miR-21 and miR-34a expression(2014)44 cited